High-Dose Chemotherapy in Ovarian Cancer: Still Waiting for the Right Study-Reference-Cited by-同舟云学术

High-Dose Chemotherapy in Ovarian Cancer: Still Waiting for the Right Study

Published:2003-01 Issue:1 Volume:88 Page:1-2
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Donato Michele L.

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference5 articles.

1. Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer;Schilder;Gynecol Oncol,2003

2. High-dose chemotherapy with hematopoietic rescue in patients with stage III to IV ovarian cancer: Long-term results;Legros;J Clin Oncol,1997

3. High-dose melphalan-based chemotherapy and autologous stem cell transplantation after second look laparotomy in patients with chemosensitive advanced ovarian carcinoma: long-term results;Bertucci;Bone Marrow Transplant,2000

4. High-dose chemotherapy with peripheral blood stem cell transplantation (PBSCT) in ovarian cancer;Ledermann;Int J Gynecol Cancer,2000

5. Phase III randomized trial of high-dose chemotherapy (HDC) and peripheral blood stem cell (PBSC) support as consolidation in patients (pts) with responsive low-burden advanced ovarian cancer (AOC): preliminary results of a GINECO/FNCLCC/SPGM-TC study;Curé;Proc Am Soc Clin Oncol,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Maintenance Therapy in Advanced Ovarian Cancer: Progression-Free Survival and Clinical Benefit;Journal of Clinical Oncology;2003-07-01

2. Cancer ovarien;Pelvi-périnéologie